A multi‐center, randomized, split face and/or neckcomparisonof 308‐nm excimer laser and0·1%tacrolimus ointmentfor stable vitiligo, plus intramuscular slow releasing betamethasone for active vitiligo

Abstract

Managing patients with vitiligo is no longer whether to treat or not to treat, but to decide what modalities are more appropriate. Both topical calcineurin inhibitors and 308‐nm excimer laser (EL) were generally accepted to treat vitiligo, and the combination of the two achieved better efficacy.However, there has been no strict comparison of the two methods in treating facial/neck vitiligo. Here we conducted a multi‐center,randomized, left‐right comparative trial in face and/or neck vitiligo,between 2012 and 2014.It was approved by medical ethics committees and official registered (ChiCTR‐TRC‐12002593). Informed consents were signed.

This article is protected by copyright. All rights reserved.

http://bit.ly/2RHdu6z